89 related articles for article (PubMed ID: 25617044)
1. Are CXCL13/CXCR5/FAK critical regulators of MSCs migration and differentiation?
Zhang Y; Ma C; Yu Y; Liu M; Yi C
Med Hypotheses; 2015 Mar; 84(3):213-5. PubMed ID: 25617044
[TBL] [Abstract][Full Text] [Related]
2. CXCR5-Overexpressing Mesenchymal Stromal Cells Exhibit Enhanced Homing and Can Decrease Contact Hypersensitivity.
Zhang X; Huang W; Chen X; Lian Y; Wang J; Cai C; Huang L; Wang T; Ren J; Xiang AP
Mol Ther; 2017 Jun; 25(6):1434-1447. PubMed ID: 28454789
[TBL] [Abstract][Full Text] [Related]
3. Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.
Del Grosso F; Coco S; Scaruffi P; Stigliani S; Valdora F; Benelli R; Salvi S; Boccardo S; Truini M; Croce M; Ferrini S; Longo L; Tonini GP
Mol Cancer Res; 2011 Jul; 9(7):815-23. PubMed ID: 21642390
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
[TBL] [Abstract][Full Text] [Related]
5. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.
El Haibi CP; Sharma PK; Singh R; Johnson PR; Suttles J; Singh S; Lillard JW
Mol Cancer; 2010 Apr; 9():85. PubMed ID: 20412587
[TBL] [Abstract][Full Text] [Related]
6. Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis.
Müller I; Vaegler M; Holzwarth C; Tzaribatchev N; Pfister SM; Schütt B; Reize P; Greil J; Handgretinger R; Rudert M
Leukemia; 2008 Nov; 22(11):2054-61. PubMed ID: 18719618
[TBL] [Abstract][Full Text] [Related]
7. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer.
Qi XW; Xia SH; Yin Y; Jin LF; Pu Y; Hua D; Wu HR
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1916-24. PubMed ID: 25010623
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
[TBL] [Abstract][Full Text] [Related]
9. CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma.
Liu JF; Lee CW; Lin CY; Chao CC; Chang TM; Han CK; Huang YL; Fong YC; Tang CH
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847038
[TBL] [Abstract][Full Text] [Related]
10. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
[TBL] [Abstract][Full Text] [Related]
11. CXCL13/CXCR5 signaling axis in cancer.
Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
[TBL] [Abstract][Full Text] [Related]
12. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
Barroso R; Martínez Muñoz L; Barrondo S; Vega B; Holgado BL; Lucas P; Baíllo A; Sallés J; Rodríguez-Frade JM; Mellado M
FASEB J; 2012 Dec; 26(12):4841-54. PubMed ID: 22913878
[TBL] [Abstract][Full Text] [Related]
13. Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13.
Halvorsen B; Smedbakken LM; Michelsen AE; Skjelland M; Bjerkeli V; Sagen EL; Taskén K; Bendz B; Gullestad L; Holm S; Biessen EA; Aukrust P
Atherosclerosis; 2014 Jun; 234(2):352-9. PubMed ID: 24732574
[TBL] [Abstract][Full Text] [Related]
14. CXCR5 overexpression in HL-60 cells enhances chemotaxis toward CXCL13 without anticipated interaction partners or enhanced MAPK signaling.
MacDonald RJ; Yen A
In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):725-735. PubMed ID: 30276608
[TBL] [Abstract][Full Text] [Related]
15. Mechanical stretch upregulates SDF-1α in skin tissue and induces migration of circulating bone marrow-derived stem cells into the expanded skin.
Zhou SB; Wang J; Chiang CA; Sheng LL; Li QF
Stem Cells; 2013 Dec; 31(12):2703-13. PubMed ID: 23836581
[TBL] [Abstract][Full Text] [Related]
16. VEGF Enhances the Migration of MSCs in Neural Differentiation by Regulating Focal Adhesion Turnover.
Wang H; Wang X; Qu J; Yue Q; Hu Y; Zhang H
J Cell Physiol; 2015 Nov; 230(11):2728-42. PubMed ID: 25820249
[TBL] [Abstract][Full Text] [Related]
17. Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Ransohoff RM; Ness JM; Colliver JA
J Neuroimmunol; 2012 Feb; 243(1-2):81-8. PubMed ID: 22264765
[TBL] [Abstract][Full Text] [Related]
18. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
19. CXCL13 promotes the effect of bone marrow mesenchymal stem cells (MSCs) on tendon-bone healing in rats and in C3HIOT1/2 cells.
Tian F; Ji XL; Xiao WA; Wang B; Wang F
Int J Mol Sci; 2015 Jan; 16(2):3178-87. PubMed ID: 25647417
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of Cd44 and Cd54.
Lisignoli G; Cristino S; Piacentini A; Cavallo C; Caplan AI; Facchini A
J Cell Physiol; 2006 May; 207(2):364-73. PubMed ID: 16331675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
